Correlation Between Bank of America and Genscript Biotech

Can any of the company-specific risk be diversified away by investing in both Bank of America and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank of America and Genscript Biotech, you can compare the effects of market volatilities on Bank of America and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Genscript Biotech.

Diversification Opportunities for Bank of America and Genscript Biotech

-0.51

Correlation Coefficient

Bank of America  Genscript Biotech

Excellent diversification

The 3 months correlation between Bank and Genscript is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of Bank of America i.e., Bank of America and Genscript Biotech go up and down completely randomly.

Pair Corralation between Bank of America and Genscript Biotech

Considering the 90-day investment horizon Bank of America is expected to under-perform the Genscript Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Bank of America is 3.55 times less risky than Genscript Biotech. The stock trades about -0.18 of its potential returns per unit of risk. The Genscript Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  126.00  in Genscript Biotech on October 7, 2024 and sell it today you would earn a total of  1.00  from holding Genscript Biotech or generate 0.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.24%
Values	Daily Returns

Bank of America  vs.  Genscript Biotech

Bank of America

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Bank of America exhibited solid returns over the last few months and may actually be approaching a breakup point.

Genscript Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genscript Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Bank of America and Genscript Biotech

The main advantage of trading using opposite Bank of America and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.

The idea behind Bank of America and Genscript Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.